Últimas noticias sobre  (IAUM)

The Trust seeks to reflect such performance before payment of the Trusts expenses and liabilities. The Shares are intended to constitute a simple and cost-effective means of making an investment similar to an investment in gold. An investment in physical gold requires expensive and sometimes complicated arrangements in connection with the assay, transportation, warehousing and insurance of the metal

iShares Gold Trust Micro ETF

iShares Gold Trust Micro Shares

Additionally, Capital Southwest's preliminary estimate of its net asset value per share as of December 31, 2024 is in the range of $16.57 to $16.62. Finally, Capital Southwest's preliminary estimate of its investment assets at fair value as of December 31, 2024 is approximately $1.7 billion.

News

Guidance

CSWC

Capital Southwest Reveals Preliminary Estimate Of Q3 Pre-tax Net Investment Income Of $0.63 - $0.64 Per Shae; Sees Net Investment Income Of $0.62 - $0.63 Per Share; Est $0.62

Fiscal 2025 Outlook:
<ul>
<li>Net revenue growth for fiscal 2025 is expected to be down 2% to 4%, adjusting for the divestiture of the Flooring business, net revenue is expected to be up 1% to 2%;</li>
<li>Organic revenue growth is expected to be flat to up 2% versus fiscal 2024;</li>
<li>Adjusted EBITDA for fiscal 2025 is expected to be in the range of $600 million to $625 million, equating to growth of approximately 1% to 5% year-on-year;</li>
<li>Adjusted EBITDA for the first quarter of 2025 is expected to be in the range of $105 million to $115 million;</li>
<li>The core tax rate, excluding the impact of discrete items, is anticipated to be between 26% and 27% in fiscal year 2025;</li>
<li>Net interest expense for fiscal 2025 is expected to be between $120 million and $125 million;</li>
<li>Adjusted EPS (diluted) is expected to be in the range of $3.90 to $4.20, equating to a range of up 2% to 9% year-on-year;</li>
<li>Operating cash flow in fiscal year 2025 is expected to be between $300 million and $325 million;</li>
<li>Capital expenditures of approximately $160 million are expected in fiscal 2025, which includes approximately $40 million related to the Company's manufacturing footprint consolidation initiative.</li>
</ul>

H.B. Fuller Fiscal 2025 Outlook, Sees Net Revenue Down 2%-4%; Organic Growth Flat To Up 2%; Adjusted EBITDA $600M-$625M, Q1 $105M-$115M; Adj. EPS $3.90-$4.20 Vs $4.22 Est.; Cash Flow $300M-$325M

Taiwan Semiconductor Manufacturing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) could share more commentary on strong semiconductor demand and how a new White House administration could boost the sector when the company reports fourth-quarter financial results before <a href="https://www.benzinga.com/earnings">the market opens Thursday.</a>
Earnings Estimates: Analysts expect Taiwan Semiconductor to report fourth-quarter revenue of $26.28 billion. That&#8217;s up from $19.62 billion in last year's fourth quarter, according to data<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011525&amp;t=be2bearmibe3na1"> from Benzinga Pro.</a>
The company has beaten analyst estimates for revenue in four straight quarters and five of the last 10 quarters overall.
Analysts expect the company to report fourth-quarter earnings per share of $2.23, up from $1.44 in last year's fourth quarter. The company beat analyst earnings per share estimates in four straight quarters and six of the last 10 quarters overall.
Guidance from the company provided after Q3 results called for fourth-quarter revenue of $26.1 billion to $26.9 billion.
What Analysts Are Saying: Strong demand for leading-edge nodes from the company could power fourth-quarter results and 2025 guidance, Goldman Sachs analyst Bruce Lu <a href="https://www.benzinga.com/25/01/42825523/taiwan-semi-likely-for-upside-backed-by-ai-demand-and-advanced-node-pricing-analyst-says">recently said.</a>
The analyst maintained a Buy rating and raised the price target from $248 to $254.
Lu sees strong momentum in artificial intelligence helping to boost revenue for Taiwan Semiconductor in 2025.
The analyst also sees a more favorable landscape for Taiwan Semiconductor against competitors like Samsung Electronics and Intel as those companies move to more advanced nodes.
Taiwan Semiconductor could raise prices and see its gross margins grow in 2025, the analyst added.
Read Also: <a href="https://www.benzinga.com/25/01/42917194/tsmc-powers-up-december-revenue-soars-ahead-of-q4-earnings-release">TSMC Powers Up: December Revenue Soars Ahead Of Q4 Earnings Release</a>
Key Items to Watch: Analysts and investors will be watching for commentary from Taiwan Semiconductor on recent reports of increased export regulations to China.
Advanced chips, including those that specialize in AI, have been a hot topic among items that are banned from being exported to China under <a href="https://www.benzinga.com/government/regulations/25/01/42897081/nvidia-and-ai-chip-stocks-brace-for-impact-as-biden-administration-considers-new-china-export-ban-report">the Biden administration</a>.
Trump is set to take office on Monday, a short time after Taiwan Semiconductor's earnings report is published. Analyst questions could center on the political conversation of the semiconductor sector and what's ahead.
The semiconductor sector saw several stocks as top performers in 2017 — Trump&#8217;s first year in the White House previously. Micron Technology and Nvidia Corporation were among the <a href="https://www.benzinga.com/general/politics/24/10/41584466/these-10-stocks-were-the-best-s-p-500-performers-in-2017-when-trump-was-president-will-history-r">10 best-performing stocks</a> in 2017 among S&amp;P 500 members.
Investors and analysts may also be looking for an update on Taiwan Semiconductor's U.S. expansion. The company expects its Arizona plant <a href="https://www.benzinga.com/government/regulations/25/01/42947562/taiwan-semiconductor-begins-4nm-chip-production-in-arizona-eyes-11-4-billion-q4-profit">to begin manufacturing </a>in 2025.
Price Action: Taiwan Semiconductor stock is up 2% to $206.06 on Wednesday versus a 52-week trading range of $100.000 to $222.20. Taiwan Semiconductor stock is up 103% over the last year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43003008/taiwan-semi-samsung-intel-may-face-stricter-us-rules-on-chip-exports-to-china-over-security-concerns">Taiwan Semi, Samsung, Intel May Face Stricter US Rules on Chip Exports to China Over Security Concerns</a></li>
</ul>
Image: Shutterstock

Previews

Tech

Trading Ideas

Taiwan Semiconductor Q4 Earnings Preview: Analysts Expect 5th Straight Beat, Will Execs Comment On Trump Impact?

The World Economic Forum's (WEF) "Global Risks Report" for 2025 paints a sobering picture of the challenges ahead. The survey, released during the <a href="https://www.benzinga.com/topic/world-economic-forum#more-news">WEF&#8217;s annual meeting in Davos</a>, Switzerland, highlights the risks of geopolitical tensions, climate change and disinformation. 
These risks call for strategies to safeguard investments while capitalizing on emerging opportunities. Here&#8217;s how some ETFs could help investors sail smoothly through each global challenge mentioned in the survey.
Armed Conflict
According to the WEF report, 23% of respondents named state-based armed conflict as the most pressing risk for 2025. Persistent geopolitical tensions, such as the Russia-Ukraine conflict and the unrest in the Middle East, have shaken global trust.
In such a dire situation, defense ETFs and global security ETFs can save the day for investors. iShares U.S. Aerospace &amp; Defense ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ITA#BATS">ITA</a>) provides exposure to U.S.-based companies in the defense sector, which could benefit from increased government spending on military capabilities. Moreover, an expense ratio of 0.4% makes it a cost-effective option. Also, a beta of 0.97% means it is at slightly lower risk than the broader market during volatility.
In addition, the SPDR S&amp;P Kensho Future Security ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FITE#NYSE">FITE</a>) focuses on innovative companies addressing global security challenges, including cybersecurity and physical defense. A glimpse of its top holdings include Viasat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSAT#NASDAQ">VSAT</a>), Lockheed Martin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) and F5 Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>). The fund boasts an expense ratio of 0.45%.
Extreme Weather
The climate crisis is intensifying the frequency and severity of weather events such as floods, heatwaves, and tornadoes. With environmental risks dominating the 10-year horizon, resilient investment strategies are the need of the hour.
Clean Energy ETFs are well-positioned to capitalize on this global challenge. Invesco Solar ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAN#NYSE">TAN</a>) has holdings in solar energy companies like Enphase Energy Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NYSE">ENPH</a>) and First Solar Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NYSE">FSLR</a>), which are poised to benefit from global decarbonization efforts.
See Also: <a href="https://www.benzinga.com/news/24/10/41594398/bill-gates-climate-innovation-model-wins-praise-from-ray-dalio-klaus-schwab-but-say-1-trillion-annua">Bill Gates&#8217; Climate Innovation Model Wins Praise From Ray Dalio, Klaus Schwab, But Say $1 Trillion Annual Funding Globally Is Not Enough</a>
Disinformation and Misinformation
For the second consecutive year, the scourge of misinformation and disinformation has been flagged by WEF as a top risk, leading to societal distrust, markets disruption, and heightened polarization. 
Many tech companies are united in their efforts to curb the spread of misinformation as well as disinformation (there is a very thin line of intentions separating the two terms). However, among those most equipped to fight this menace are cybersecurity companies. Naturally, <a href="https://www.benzinga.com/25/01/42829188/hack-attack-cybercrime-surge-fuels-demand-for-cybersecurity-etfs">ETFs focusing on the cybersecurity sector</a> stand to gain.
First Trust Nasdaq Cybersecurity ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIBR#NASDAQ">CIBR</a>) focuses on companies addressing cyber threats, which often fan the fire of misinformation. Stocks of companies like Broadcom, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), Crowdstrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) and Cisco Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>), prominent players in the cybersecurity space, are part of this fund&#8217;s holdings. 
Media ETFs like the Communication Services Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>) can also benefit from media firms, which are increasingly becoming content-conscious. Media firms may benefit from investing in trusted content creation and digital information technologies.
Why ETFs Are Ideal In Turbulent Times
Insights from over 900 global risk experts, policymakers and industry leaders in September and October last year were obtained to compile WEF&#8217;s survey report. Some of the other short-term risks that the WEF's report highlights include societal polarization, cyber espionage, pollution, and inequality.
In these turbulent times, investors seek to hedge their investments instead of holding back from the market. ETFs come into the picture as flexible, cost-efficient and concern-specific instruments that allow investors to diversify their portfolios across sectors and geographies during global uncertainties.
As Carolina Klint of Marsh McLennan Europe told CNBC, "I think we're navigating an era now marked by increasing economic tensions&#8230;And I think we have to recognize the fragmentation is not a theoretical concern. It is something that we need to confront today. So, it has resulted in a more complex and uncertain trading environment." 
Building a resilient portfolio with ETFs aligned to global challenges can help investors power through 2025.
See Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/new-etfs/25/01/43010401/maximize-growth-minimize-risk-with-new-dynamic-allocation-etf">Maximize Growth, Minimize Risk With New, Dynamic Allocation ETF</a></li>
</ul>
Photo: Shutterstock

Specialty ETFs

Emerging Market ETFs

Global

ETFs

ANEW

AVGO

CIBR

CRWD

CSCO

ENPH

FFIV

FITE

FSLR

iShares Dow Jones US Aerospace & Defense Index Fund

VSAT

Davos 2025: ETFs To Tackle Geopolitical, Climate, Cyber Risks

The Q4 earnings report for H.B. Fuller (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) was released on Wednesday, January 15, 2025 at 04:05 PM.
Here's what investors need to know about the latest announcement.
<h3>Earnings</h3>
H.B. Fuller missed estimated earnings by -8.0%, reporting an EPS of $0.92 versus an estimate of $1.0.
Revenue was up $20.41 million from the same period last year.
<h3>Analysis of Past Earnings</h3>
The company missed on EPS by $0.1 in the last quarter, resulting in a 0.0% increase share price change the following day.
Here's a look at H.B. Fuller's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.23</td>
<td>1.03</td>
<td>0.64</td>
<td>1.27</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.13</td>
<td>1.12</td>
<td>0.67</td>
<td>1.32</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>944.25M</td>
<td>913.23M</td>
<td>825.03M</td>
<td>932.16M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>917.93M</td>
<td>917.11M</td>
<td>810.42M</td>
<td>902.88M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
H.B. Fuller management provided guidance for FY 2024, expecting earnings between $3.84 and $3.84 per share.
To track all earnings releases for H.B. Fuller <a href="https://www.benzinga.com/quote/FUL/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

H.B. Fuller Earnings Report: Q4 Overview

Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) reported its Q4 earnings results on Wednesday, January 15, 2025 at 04:05 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Concentrix beat estimated earnings by 8.0%, reporting an EPS of $3.26 versus an estimate of $3.01.
Revenue was up $217.00 million from the same period last year.
<h3>Analysis of Past Earnings</h3>
In the previous quarter, the company missed on EPS by $0.06, resulting in a 19.0% drop change in the share price the following day.
Here's a look at Concentrix's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>2.93</td>
<td>2.62</td>
<td>2.58</td>
<td>3.08</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.87</td>
<td>2.69</td>
<td>2.57</td>
<td>3.36</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>2.38B</td>
<td>2.35B</td>
<td>2.38B</td>
<td>2.20B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>2.39B</td>
<td>2.38B</td>
<td>2.40B</td>
<td>2.23B</td>
</tr>
</tbody>
</table>

To track all earnings releases for Concentrix <a href="https://www.benzinga.com/quote/CNXC/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CNXC

Concentrix: Q4 Earnings Insights

Biotech

General

Eli Lilly Announces The FDA Has Approved Omvoh For The Treatment Of Moderately To Severely Active Crohn's Disease in Adults

WIIM

PMAX

Powell Max shares are trading higher after the company announced acquisition plans and is targeting firms with between $1 million and $5 million in revenue to expand into the Hong Kong and Asian financial communications market.

Concentrix shares are trading lower following soft guidance.

Concentrix Sees Q1 Non-GAAP EPS $2.49-$2.64 vs $2.85 Est., Revenue $2.355B-$2.370B vs $2.409B Est.; Sees FY25 Non-GAAP EPS $11.18-$11.77 vs $11.97 Est., Revenue $9.470B-$9.610B vs $9.726B Est.

- Duchenne: Dosed four patients in INSPIRE DUCHENNE clinical trial; SGT-003 has been well tolerated in all patients with no SAEs observed; initial three patient data expected Q1 2025 -
- FA: First-in-human clinical study of SGT-212 utilizing a dual route of administration to treat Friedreich's ataxia (FA) anticipated in 2H 2025 following recent FDA IND clearance -
- CPVT: Submission of IND for SGT-501 on track for 1H 2025; the submission will expand clinical-stage portfolio to three unique candidates in diverse indications with significant unmet need -
- Cash: Company enters 2025 with approximately&nbsp;$148.9 million&nbsp;in cash and investments1 as of 12/31/2024; expected to fund key strategic priorities into 2026 -
CHARLESTOWN, Mass., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDB#NASDAQ">SLDB</a>) (the "Company" or "Solid"), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, will provide a corporate update outlining the Company's expanded clinical-stage pipeline and 2025 objectives as it completes its transformation into a multi-program leader in the development of precision genetic medicines. Bo Cumbo, President and CEO, and Gabriel Brooks, M.D., Chief Medical Officer, will provide the update at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 3:45 p.m. PT (6:45 p.m. ET).

SLDB

Solid Biosciences Announces Clinical Pipeline Updates: SGT-003 Tolerated In Duchenne Trial; SGT-212 FA Study For 2H 2025; SGT-501 IND Submission By H1 2025; $148.9M Cash Funding Through 2026

The transaction was finalized on December 23, 2024 and eliminated $11.2 million in associated subsidiary-level debt, positioning Serina with a debt-free balance sheet heading into 2025.

Asset Sales

Serina Therapeutics Divests Its UniverXome Subsidiary; Transaction Eliminates $11.2M In Debt

LKCO

Luokung Announces Nasdaq Notification

Buybacks

Concentrix Increases Share Repurchase Authorization To $600M

<h3>Gainers</h3>
<ul>
<li>Vision Marine Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMAR#NASDAQ">VMAR</a>) shares increased by 45.7% to $2.04 during Wednesday's pre-market session. The market value of their outstanding shares is at $5.8 million. As per the news, the Q1 earnings report came out 2 days ago. </li>
<li>Naas Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAAS#NASDAQ">NAAS</a>) shares increased by 14.9% to $1.85. The market value of their outstanding shares is at $25.4 million. </li>
<li>SharpLink Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) stock moved upwards by 14.77% to $0.55. The company's market cap stands at $1.9 million. </li>
<li>Fitell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) stock moved upwards by 12.48% to $8.92. The company's market cap stands at $179.3 million. </li>
<li>Brilliant Earth Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRLT#NASDAQ">BRLT</a>) stock rose 11.76% to $1.9. The market value of their outstanding shares is at $25.8 million. </li>
<li>Motorcar Parts of America (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MPAA#NASDAQ">MPAA</a>) stock increased by 10.84% to $6.95. The market value of their outstanding shares is at $137.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Algorhythm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIME#NASDAQ">RIME</a>) stock decreased by 26.7% to $0.06 during Wednesday's pre-market session. The market value of their outstanding shares is at $5.3 million. </li>
<li>Homestolife (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTLM#NASDAQ">HTLM</a>) stock fell 11.13% to $6.71. The market value of their outstanding shares is at $98.5 million. </li>
<li>Bally's Corporation Common Stock (Rolling Shares) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BALY#NYSE">BALY</a>) stock fell 7.88% to $18.25. </li>
<li>MKDWell Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKDW#NASDAQ">MKDW</a>) shares decreased by 6.73% to $0.56. The market value of their outstanding shares is at $9.4 million. </li>
<li>Premium Catering (Hldgs) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PC#NASDAQ">PC</a>) stock decreased by 6.65% to $0.67. The market value of their outstanding shares is at $10.6 million. </li>
<li>Color Star Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADD#NASDAQ">ADD</a>) stock declined by 6.3% to $1.79. The company's market cap stands at $1.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

BALY

BRLT

FTEL

HTLM

MKDW

MPAA

NAAS

RIME

SBET

VMAR

12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>OS Therapies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OSTX#AMEX">OSTX</a>) shares rose 57.9% to $6.57 during Wednesday's pre-market session. The market value of their outstanding shares is at $139.5 million. </li>
<li>Helius Medical Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSDT#NASDAQ">HSDT</a>) shares rose 24.29% to $0.86. The company's market cap stands at $3.2 million. </li>
<li>Quantum-Si (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSI#NASDAQ">QSI</a>) shares rose 18.71% to $2.41. The company's market cap stands at $381.5 million. </li>
<li>Lexaria Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEXX#NASDAQ">LEXX</a>) stock moved upwards by 15.54% to $2.23. The market value of their outstanding shares is at $39.1 million. The company's, Q1 earnings came out 3 days ago. </li>
<li>MetaVia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTVA#NASDAQ">MTVA</a>) stock increased by 14.63% to $2.34. The company's market cap stands at $20.1 million. </li>
<li>AlloVir (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALVR#NASDAQ">ALVR</a>) shares increased by 13.74% to $0.46. The company's market cap stands at $52.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Aclarion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACON#NASDAQ">ACON</a>) stock fell 48.8% to $0.05 during Wednesday's pre-market session. </li>
<li>Anitra (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AZTR#AMEX">AZTR</a>) shares decreased by 32.17% to $0.29. The market value of their outstanding shares is at $2.1 million. </li>
<li>GlucoTrack (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) stock fell 27.63% to $0.09. The market value of their outstanding shares is at $1.4 million. </li>
<li>Keros Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KROS#NASDAQ">KROS</a>) stock fell 19.8% to $10.01. The company's market cap stands at $405.4 million. </li>
<li>Phio Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHIO#NASDAQ">PHIO</a>) shares fell 17.04% to $2.97. The market value of their outstanding shares is at $5.1 million. </li>
<li>Ardent Health Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARDT#NYSE">ARDT</a>) shares declined by 14.52% to $12.01. The company's market cap stands at $1.7 billion. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACON

ALVR

ARDT

AZTR

GCTK

HSDT

KROS

LEXX

MTVA

OSTX

PHIO

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Safe &amp; Green Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) shares moved upwards by 240.7% to $1.84 during Wednesday's pre-market session. The company's market cap stands at $8.0 million. </li>
<li>Richtech Robotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RR#NASDAQ">RR</a>) shares moved upwards by 15.38% to $3.0. The market value of their outstanding shares is at $284.4 million. </li>
<li>SES AI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) shares moved upwards by 13.21% to $0.93. The company's market cap stands at $332.1 million. </li>
<li>Nauticus Robotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KITT#NASDAQ">KITT</a>) stock increased by 13.09% to $2.24. The company's market cap stands at $14.3 million. </li>
<li>Palladyne AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDYN#NASDAQ">PDYN</a>) shares rose 11.61% to $10.09. The company's market cap stands at $303.8 million. </li>
<li>Beacon Roofing Supply (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BECN#NASDAQ">BECN</a>) shares increased by 11.16% to $121.0. The company's market cap stands at $7.4 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Li-Cycle Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LICY#NYSE">LICY</a>) stock fell 39.5% to $0.92 during Wednesday's pre-market session. The company's market cap stands at $25.3 million. </li>
<li>Shoals Technologies Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>) shares fell 11.98% to $5.0. The market value of their outstanding shares is at $833.4 million. </li>
<li>Nocera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCRA#NASDAQ">NCRA</a>) stock decreased by 10.29% to $0.96. The company's market cap stands at $13.4 million. </li>
<li>Energy Focus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EFOI#NASDAQ">EFOI</a>) shares fell 8.89% to $1.23. The market value of their outstanding shares is at $6.4 million. </li>
<li>Singularity Future Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGLY#NASDAQ">SGLY</a>) stock declined by 8.8% to $2.23. The market value of their outstanding shares is at $7.8 million. </li>
<li>Nuburu (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BURU#AMEX">BURU</a>) stock decreased by 8.55% to $0.43. The market value of their outstanding shares is at $8.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BECN

BURU

EFOI

KITT

LICY

NCRA

PDYN

SGBX

SGLY

SHLS

12 Industrials Stocks Moving In Wednesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Arqit Quantum (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARQQ#NASDAQ">ARQQ</a>) shares moved upwards by 36.1% to $24.57 during Wednesday's pre-market session. The company's market cap stands at $307.2 million. </li>
<li>SEALSQ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAES#NASDAQ">LAES</a>) shares moved upwards by 31.14% to $4.8. The company's market cap stands at $377.0 million. </li>
<li>908 Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASS#NASDAQ">MASS</a>) shares moved upwards by 27.27% to $2.52. The market value of their outstanding shares is at $87.7 million. </li>
<li>D-Wave Quantum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) shares increased by 24.73% to $5.9. The market value of their outstanding shares is at $1.5 billion. </li>
<li>Quantum (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QMCO#NASDAQ">QMCO</a>) stock rose 24.54% to $27.91. The company's market cap stands at $135.3 million. </li>
<li>Quantum Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) stock rose 17.76% to $8.75. The company's market cap stands at $1.1 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Baijiayun Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RTC#NASDAQ">RTC</a>) shares declined by 15.9% to $1.8 during Wednesday's pre-market session. The market value of their outstanding shares is at $46.1 million. </li>
<li>Cyngn (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) stock decreased by 8.45% to $0.57. The market value of their outstanding shares is at $12.3 million. </li>
<li>nLight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LASR#NASDAQ">LASR</a>) shares decreased by 6.86% to $10.33. The market value of their outstanding shares is at $500.2 million. </li>
<li>LGL Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LGL#AMEX">LGL</a>) shares fell 6.52% to $6.03. The company's market cap stands at $32.3 million. </li>
<li>Gryphon Digital Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRYP#NASDAQ">GRYP</a>) stock declined by 6.28% to $0.42. The company's market cap stands at $21.5 million. </li>
<li>Digital Ally (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGLY#NASDAQ">DGLY</a>) stock fell 6.23% to $0.39. The company's market cap stands at $2.1 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARQQ

DGLY

GRYP

LAES

LASR

MASS

QBTS

QMCO

QUBT

12 Information Technology Stocks Moving In Wednesday's Pre-Market Session

H.B. Fuller (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) reported quarterly earnings of $0.92 per share which missed the analyst consensus estimate of $1.00 by 8 percent. This is a 30.3 percent decrease over earnings of $1.32 per share from the same period last year. The company reported quarterly sales of $923.28 million which beat the analyst consensus estimate of $916.77 million by 0.71 percent. This is a 2.26 percent increase over sales of $902.88 million the same period last year.

Earnings Beats

Earnings Misses

H.B. Fuller Q4 Adj EPS $0.92 Misses $1.00 Estimate, Sales $923.28M Beat $916.77M Estimate

Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) reported quarterly earnings of $3.26 per share which beat the analyst consensus estimate of $3.01 by 8.31 percent. The company reported quarterly sales of $2.448 billion which beat the analyst consensus estimate of $2.441 billion by 0.30 percent. This is a 9.73 percent increase over sales of $2.231 billion the same period last year.

Concentrix Q4 2024 Adj. EPS $3.26 Beats $3.01 Estimate, Sales $2.448B Beat $2.441B Estimate

Gold Price Outlook: Bulls To Take Charge? U.S. Services PMI Ahead

Why Did COMEX And DXY Start Trading Together?

The Next Phase Of Gold's Bull Market Could Be Starting Soon (Technical Analysis)

Comments

Noticias

Últimas noticias sobre (IAUM)

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL